Variant report
Variant | esv1008555 |
---|---|
Chromosome Location | chr1:209409577-209416496 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:209412016..209414159-chr1:209416061..209418211,2 | K562 | blood: | |
2 | chr1:209412016..209414159-chr1:209416061..209418211,2 | K562 | blood: | |
3 | chr1:209414000..209416153-chr1:209437703..209440294,2 | MCF-7 | breast: | |
4 | chr1:209401346..209403763-chr1:209407691..209409973,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146078828 | chr1:209409614-209409615 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs558927800 | chr1:209409635-209409636 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs562751850 | chr1:209409772-209409773 | Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs61536866 | chr1:209409790-209409791 | Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs537980568 | chr1:209409844-209409845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs186597128 | chr1:209409858-209409859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs77145131 | chr1:209409864-209409865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs17014177 | chr1:209409885-209409886 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs116534545 | chr1:209409931-209409932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571235751 | chr1:209409944-209409945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs538951847 | chr1:209409953-209409954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189770171 | chr1:209409984-209409985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs78617472 | chr1:209410009-209410010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs536046336 | chr1:209410012-209410013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182996190 | chr1:209410082-209410083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs573233419 | chr1:209410093-209410094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571244304 | chr1:209410098-209410099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs540692996 | chr1:209410119-209410120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs139601581 | chr1:209410139-209410140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs372419805 | chr1:209410142-209410143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs544506252 | chr1:209410174-209410175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562839318 | chr1:209410182-209410183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576947638 | chr1:209410244-209410245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs76323445 | chr1:209410289-209410290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs116307959 | chr1:209410314-209410315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201803750 | chr1:209410346-209410347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs143486134 | chr1:209410347-209410348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs115642122 | chr1:209410400-209410401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549173204 | chr1:209410406-209410407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561184343 | chr1:209410456-209410457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs368500137 | chr1:209410478-209410479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs191425375 | chr1:209410495-209410496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs183252491 | chr1:209410516-209410517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs550943865 | chr1:209410534-209410535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188610764 | chr1:209410535-209410536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs536471988 | chr1:209410566-209410567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs547499627 | chr1:209410601-209410602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192276974 | chr1:209410610-209410611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs116036974 | chr1:209410680-209410681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183161440 | chr1:209410688-209410689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539436680 | chr1:209410806-209410807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs115421402 | chr1:209410812-209410813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs537840058 | chr1:209410872-209410873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs2800916 | chr1:209410881-209410882 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs187890808 | chr1:209410894-209410895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs17260245 | chr1:209411025-209411026 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs534491486 | chr1:209411155-209411156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs191141005 | chr1:209411159-209411160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572561763 | chr1:209411170-209411171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs199506997 | chr1:209411183-209411184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21611746 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Macular degeneration | 22558131 | CNVD |
Alzheimer''s disease | 21403675 | CNVD |
Multiple myeloma | 16461302 | CNVD |
van der Woude syndrome | 22470819 | CNVD |
van der Woude syndrome | 20818247 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 17060936 | CNVD |
Atypical hemolytic uremic syndrome | 19861685 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 20406844 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:209409000-209409800 | Strong transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr1:209409800-209422200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr1:209411600-209412000 | Enhancers | HMEC | breast |
4 | chr1:209411600-209412200 | Enhancers | NHEK | skin |
5 | chr1:209411600-209412400 | Enhancers | HUVEC | blood vessel |
6 | chr1:209411800-209412200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
7 | chr1:209413800-209414000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |